Frederick H. Davidorf

4.1k total citations
85 papers, 2.0k citations indexed

About

Frederick H. Davidorf is a scholar working on Ophthalmology, Oncology and Molecular Biology. According to data from OpenAlex, Frederick H. Davidorf has authored 85 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Ophthalmology, 19 papers in Oncology and 17 papers in Molecular Biology. Recurrent topics in Frederick H. Davidorf's work include Ocular Oncology and Treatments (37 papers), Cutaneous Melanoma Detection and Management (14 papers) and Glaucoma and retinal disorders (9 papers). Frederick H. Davidorf is often cited by papers focused on Ocular Oncology and Treatments (37 papers), Cutaneous Melanoma Detection and Management (14 papers) and Glaucoma and retinal disorders (9 papers). Frederick H. Davidorf collaborates with scholars based in United States, Egypt and United Kingdom. Frederick H. Davidorf's co-authors include Mohamed H. Abdel‐Rahman, Colleen M. Cebulla, James B. Massengill, Robert Pilarski, Getachew Boru, Benjamin Christopher, Robert J. Derick, Robert B. Chambers, Peter Hovland and Andrew K. Vine and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Cancer.

In The Last Decade

Frederick H. Davidorf

83 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frederick H. Davidorf United States 26 1.4k 575 452 373 237 85 2.0k
Zélia M. Corrêa United States 21 1.1k 0.8× 430 0.7× 424 0.9× 324 0.9× 117 0.5× 127 1.4k
Walter D. Foster United States 14 1.1k 0.8× 398 0.7× 440 1.0× 197 0.5× 98 0.4× 23 1.5k
Per Lindnér Sweden 23 325 0.2× 472 0.8× 661 1.5× 69 0.2× 170 0.7× 80 1.6k
B. R. Straatsma United States 16 1.1k 0.8× 330 0.6× 302 0.7× 387 1.0× 94 0.4× 44 1.5k
Ami B. Patel United States 22 222 0.2× 586 1.0× 805 1.8× 76 0.2× 161 0.7× 62 1.8k
Feras M. Ghazawi Canada 21 123 0.1× 272 0.5× 434 1.0× 59 0.2× 140 0.6× 71 1.3k
Pravin U. Dugel United States 48 6.3k 4.5× 1.4k 2.4× 129 0.3× 4.4k 11.7× 82 0.3× 151 7.1k
David Callanan United States 31 2.4k 1.7× 306 0.5× 61 0.1× 1.1k 3.0× 137 0.6× 69 3.0k
An Song United States 20 88 0.1× 1.1k 1.9× 381 0.8× 684 1.8× 104 0.4× 39 1.8k

Countries citing papers authored by Frederick H. Davidorf

Since Specialization
Citations

This map shows the geographic impact of Frederick H. Davidorf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick H. Davidorf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick H. Davidorf more than expected).

Fields of papers citing papers by Frederick H. Davidorf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick H. Davidorf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick H. Davidorf. The network helps show where Frederick H. Davidorf may publish in the future.

Co-authorship network of co-authors of Frederick H. Davidorf

This figure shows the co-authorship network connecting the top 25 collaborators of Frederick H. Davidorf. A scholar is included among the top collaborators of Frederick H. Davidorf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederick H. Davidorf. Frederick H. Davidorf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Massengill, James B., et al.. (2021). BAP1 status and response to radiation in melanoma. Investigative Ophthalmology & Visual Science. 62(8). 2872–2872. 1 indexed citations
2.
Davidorf, Frederick H., et al.. (2020). Mediators of the relationship between socioeconomic status and visual acuity in age-related macular degeneration. Investigative Ophthalmology & Visual Science. 61(7). 1572–1572. 1 indexed citations
3.
Binkley, Elaine M., Dimosthenis Mantopoulos, Matthew Ohr, et al.. (2019). Known and novel ocular toxicities of biologics, targeted agents, and traditional chemotherapeutics. Graefe s Archive for Clinical and Experimental Ophthalmology. 257(8). 1771–1781. 30 indexed citations
4.
Dougherty, Bradley E., et al.. (2018). Vision, Stress, Depression, and Number of Anti-VEGF Treatments in Age-related Macular Degeneration. Investigative Ophthalmology & Visual Science. 59(9). 5192–5192. 2 indexed citations
5.
Abdel‐Rahman, Mohamed H., Leili Shahriyari, James B. Massengill, et al.. (2018). Identification of novel targeted therapies for BAP1 mutated tumors. Investigative Ophthalmology & Visual Science. 59(9). 4958–4958. 1 indexed citations
6.
Boru, Getachew, et al.. (2016). Mechanisms of somatic biallelic inactivation of BAP1 in uveal melanoma. Investigative Ophthalmology & Visual Science. 57(12). 5895–5895. 1 indexed citations
7.
Ferguson, Robert, Matjaž Vogelsang, Karan Rai, et al.. (2016). Genetic markers of pigmentation are novel risk loci for uveal melanoma. Scientific Reports. 6(1). 31191–31191. 30 indexed citations
8.
Rai, Karan, Robert Pilarski, Getachew Boru, et al.. (2016). Germline BAP1 alterations in familial uveal melanoma. Genes Chromosomes and Cancer. 56(2). 168–174. 45 indexed citations
9.
Dougherty, Bradley E., et al.. (2015). The Relationship between Perceived Stress and Self-reported Visual Function in Patients with Neovascular Age-related Macular Degeneration (AMD). Investigative Ophthalmology & Visual Science. 56(7). 1370–1370. 1 indexed citations
10.
Abdel‐Rahman, Mohamed H., et al.. (2011). Monosomy 3 Status of Metastatic Uveal Melanomas is Associated with Rapidly Aggressive, Therapy-Resistant Tumors. Investigative Ophthalmology & Visual Science. 52(14). 5383–5383. 1 indexed citations
11.
Abdel‐Rahman, Mohamed H., Robert Pilarski, Sameera Ezzat, J. Sexton, & Frederick H. Davidorf. (2010). Cancer family history characterization in an unselected cohort of 121 patients with uveal melanoma. Familial Cancer. 9(3). 431–438. 27 indexed citations
12.
Davidorf, Frederick H., et al.. (2007). Higher Colon Cancer Risk in Uveal Melanoma Patients and Their Relatives Compared to General Population. Investigative Ophthalmology & Visual Science. 48(13). 4790–4790. 1 indexed citations
13.
Yang, Yuanquan, et al.. (2005). Anti–Angiogenic Effect of Linomide Analogue. Investigative Ophthalmology & Visual Science. 46(13). 4166–4166. 1 indexed citations
14.
Gupta, Saurabh, et al.. (2003). Assessment of Endothelial Progenitor Cells in the Peripheral Blood of Patients with Diabetic Retinopathy. Investigative Ophthalmology & Visual Science. 44(13). 564–564. 1 indexed citations
15.
Chorich, Louis J., Frederick H. Davidorf, Robert B. Chambers, & Paul A. Weber. (1998). Bungee cord-associated ocular injuries. American Journal of Ophthalmology. 125(2). 270–272. 17 indexed citations
16.
Chambers, Robert B., et al.. (1997). Interferon alfa-associated retinopathy. Journal of Osteopathic Medicine. 97(1). 43–43. 14 indexed citations
17.
Williams, Lowell L., et al.. (1994). Altered membrane fatty acids of cultured human retinal pigment epithelium persistently infected with rubella virus may affect secondary cellular function. Archives of Virology. 134(3-4). 379–392. 6 indexed citations
18.
Davidorf, Frederick H.. (1983). Incidence of Misdiagnosed and Unsuspected Choroidal Melanomas. Archives of Ophthalmology. 101(3). 410–410. 26 indexed citations
19.
Letson, Alan D. & Frederick H. Davidorf. (1982). Bilateral Retinal Metastases From Cutaneous Malignant Melanoma. Archives of Ophthalmology. 100(4). 605–607. 30 indexed citations
20.
Davidorf, Frederick H.. (1973). Battery Explosions: A Hazard to Health. JAMA. 223(13). 1509–1509. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zélia M. Corrêa Breakdown of academic impact, for papers by Walter D. Foster Breakdown of academic impact, for papers by Per Lindnér Breakdown of academic impact, for papers by B. R. Straatsma Breakdown of academic impact, for papers by Ami B. Patel Breakdown of academic impact, for papers by Feras M. Ghazawi Breakdown of academic impact, for papers by Pravin U. Dugel Breakdown of academic impact, for papers by David Callanan Breakdown of academic impact, for papers by An Song
Rankless by CCL
2026